ANATOMIC STAGE III BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE III BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE III BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: drug aims to boost immune attack
Disease control TerminatedThis study tested the drug abemaciclib in 26 women with triple negative breast cancer that did not respond to standard chemotherapy. The goal was to see if the drug could increase immune cell activity in the tumor before surgery. The trial was stopped early, but results may help …
Matched conditions: ANATOMIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
Promising combo for Hard-to-Treat breast cancer hits roadblock
Disease control TerminatedThis study tested a combination of two drugs (nab-paclitaxel and alpelisib) given before surgery to people with a specific type of triple-negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the combo could shrink or eliminate tumors. Only 6…
Matched conditions: ANATOMIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
Hot flash drug studied in breast cancer patients – trial cut short
Symptom relief TerminatedThis study tested fezolinetant, a drug for hot flashes and night sweats, in women with breast cancer taking hormone therapy. The trial aimed to see if the drug could reduce the number and severity of these symptoms. Only 9 people took part before the study was stopped early.
Matched conditions: ANATOMIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 07:54 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: ANATOMIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC
-
Cancer trial uses DNA tests to pick drugs, but stops early
Knowledge-focused TerminatedThis study tested a precision medicine approach for people with advanced cancers like breast, prostate, or pancreatic cancer. Researchers used genetic and protein tests to track how each person's cancer changed over time, then a team of experts recommended personalized drugs. The…
Matched conditions: ANATOMIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:54 UTC